Product
NORA520
Aliases
NORA520 Dose 1, NORA520 Dose 2
1 clinical trial
4 indications
Indication
Major Depressive DisorderIndication
PostpartumIndication
Postpartum DepressionIndication
Postnatal DepressionClinical trial
A Randomized, Placebo-Controlled, Double-Blinded, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Oral NORA520 in Female Adults With Severe Postpartum DepressionStatus: Not yet recruiting, Estimated PCD: 2026-02-01